Recent PALI News
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/22/2026 04:15:18 AM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/15/2026 08:14:23 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 05/12/2026 09:27:33 PM
- Palisade Bio Reports First Quarter 2026 Financial Results and Highlights Continued Clinical Progress of PALI-2108 • GlobeNewswire Inc. • 05/12/2026 08:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/12/2026 08:14:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/12/2026 08:04:23 PM
- Palisade Bio Reports Additional Phase 1a/b Data Demonstrating Colon-Targeted Exposure and Sustained IC90 Coverage Supporting Once-Daily Dosing in Ulcerative Colitis • GlobeNewswire Inc. • 05/05/2026 12:30:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/29/2026 08:49:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/29/2026 08:49:19 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 04/17/2026 08:30:34 PM
- Palisade Bio Announces Abstract Selected for Poster Presentation at Digestive Disease Week (DDW) 2026 • GlobeNewswire Inc. • 04/16/2026 12:50:00 PM
- Palisade Bio to Present at the Needham & Co. 25th Annual Healthcare Conference • GlobeNewswire Inc. • 04/08/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 12:34:41 PM
- Palisade Bio Reports Positive Topline Data from Phase 1b Clinical Study of PALI-2108 in Fibrostenotic Crohn’s Disease • GlobeNewswire Inc. • 03/30/2026 08:01:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/20/2026 08:22:38 PM
- Palisade Bio Announces Participation in Two Upcoming Investor Conferences • GlobeNewswire Inc. • 03/02/2026 02:00:00 PM
- Palisade Bio Reports Rapid Clinical, Histologic and New Mechanistic Colon Tissue RNA Sequencing Data Supporting Targeted Activity of PALI-2108 at ECCO 2026 • GlobeNewswire Inc. • 02/23/2026 01:40:00 PM
- Palisade Bio Appoints Global IBD Precision Medicine Leader Bram Verstockt, MD, PhD to Clinical Advisory Board • GlobeNewswire Inc. • 02/17/2026 01:45:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2026 01:10:12 AM
